CPT2 and cancer: Additionally, CPT1A overexpression has been associated with chemoresistance in multiple cancer types, and it has been observed that cancer cells surviving radiotherapy and chemotherapy enhance fatty acid oxidation through CPT1 and CPT2 [29,30].